A phase II study of robot assisted gastrectomy with nodal dissection for clinical stage IA and IB gastric cancer
Phase 2
- Conditions
- Patients with clinical stage IA or IB gastric cancer
- Registration Number
- JPRN-UMIN000027914
- Lead Sponsor
- Shizuoka General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
1) Having other active cancers 2) Possibly pregnant, or breast feeding woman 3) with psychiatric disorder 4) Receiving steroids 5) With Acute myocardial infaction in 6 months or with unstable ungina 6) With uncontrolled hypertention 7) With uncontrolled diabetes mellitus 8) With pulmonary disease and require continuous oxygen therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of post-operative intra-abdominal infectious complications (anastomotic leakage, pancreas related infection, and intra-abdominal abscess)
- Secondary Outcome Measures
Name Time Method Oveall survival Relapse free survival Completion rate of robot assised surgery The incidence of adverse event
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie robotic gastrectomy's efficacy in stage IA/B gastric cancer?
How does robot-assisted gastrectomy compare to open surgery in treating clinical stage IA and IB gastric cancer?
Are there specific biomarkers that predict better outcomes with robotic nodal dissection in gastric cancer?
What are the potential adverse events associated with robotic gastrectomy for early-stage gastric cancer?
What are the current combination therapies being explored alongside robotic gastrectomy for gastric cancer?